New Immunotherapeutic Agents Broaden Treatment Options for Chronic Lymphocytic Leukemia
EP. 1: Novel Therapies in CLL
January 9th 2019
EP. 2: Treatment Strategies With Ibrutinib in CLL
January 9th 2019
EP. 3: Treatment Resistance With Novel Therapies in CLL
January 9th 2019
EP. 4: Venetoclax Plus Rituximab in Relapsed/Refractory CLL
January 9th 2019
EP. 5: CLL: Next Steps in Research
January 9th 2019
